Hospital Acquired Infection Control Market Analysis, Size, Share, and Forecast 2031

Comments · 87 Views

The Hospital Acquired Infection Control Market in 2023 is US$ 35.29 billion, and is expected to reach US$ 76.31 billion by 2031 at a CAGR of 10.12%.

The Hospital Acquired Infection Control Market in 2023 is US$ 35.29 billion, and is expected to reach US$ 76.31 billion by 2031 at a CAGR of 10.12%.

FutureWise Research published a report that analyzes Hospital Acquired Infection Control Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Hospital Acquired Infection Control research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

 

Request a Sample Report @ Request for Hospital Acquired Infection Control Market Sample

 

Hospital Acquired Infection Control Market Segmentation:

By Product

·        Sterilizers

·        Disinfectors

·        Endoscope Reprocessors

·        Disinfectants

·        Disinfectants Market, By Product

·        Hand Disinfectants

·        Skin Disinfectants

·        Instrument Disinfectants

·        Surface Disinfectants/Disinfectant Robots

·        Disinfectants Market, By Formulation

·        Disinfectant Wipes

·        Disinfectant Liquids

·        Disinfectant Sprays

·        Medical Nonwovens

By Testing Market

·        By Product

·        Microbial Testing Instruments

·        Automated Microbial Identification Systems

·        Polymerase Chain Reaction (PCR) Instruments

·        Mass Spectrometers

·        Microarrays

·        Polystainers

·        Flow Cytometers

·        Others

·        Reagents and Consumables

·        Infection Prevention and Surveillance Software

·        By Application

·        Disease Testing

·        Drug-resistance Testing

·        By Technology

·        Phenotypic Methods

·        Phage-based Assays

·        Colorimetric Methods

·        Nitrate Reductase Assay

·        Genotypic Methods

·        DNA Sequencing

·        Solid-phase Hybridization Techniques

·        Polymerase Chain Reaction Techniques

·        Microarrays

By Disease

·        Hospital acquired Pneumonia

·        Bloodstream infections

·        Surgical site infections

·        Gastrointestinal Infections

·        Urinary Tract infections (UTI)

·        Others

By End User

·        Hospitals and Intensive Care Units (ICUs)

·        Ambulatory Surgical and Diagnostic Centers

·        Nursing Homes and Maternity Centers

·        Others

By Region

·        North America

·        Europe

·        Asia-Pacific

·        Latin America

·        Middle East and Africa

 

Major players included in the Hospital Acquired Infection Control Market:

·        Becton, Dickinson and Company

·        Steris Corporation

·        Advanced Sterilization Products 

·        Getinge Group

·        Kimberly-Clark Corporation

·        Cantel Medical

·        BioMérieux SA

·        Belimed AG

·        3M Company

·        Sterigenics I

Comments